First-Line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum - International Study

• Status: Completed
• Trial end date: 2013-10-01
• Target enrollment: 0
• Participant gender: All

Summary

First-Line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: King Faisal Specialist Hospital & Research Center
• Treatments: Bevacizumab

Criteria

Inclusion Criteria:

• Patients with metastatic cancer of colon or rectum